HER2-Positive Breast Cancer: Incidence, Prognosis, and Treatment Options

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.2, Iss.3, 2003-01, pp. : 169-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe

By Piccart M.J.

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia Pronzato Paolo Del Mastro Lucia

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

HER2-Positive Breast Cancer: Current Treatment Strategies

By Perez Edith Baweja Mansoina

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

By Lobbezoo Dorien Kampen Roel Voogd Adri Dercksen M. den Berkmortel Franchette Smilde Tineke Wouw Agnes Peters Frank Riel Johanna Peters Natascha Boer Maaike Borm George Tjan-Heijnen Vivianne

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 507-514

Springer Publishing Company

Access to resources Recommend Favorite